Nivolumab/Ipilimumab and Chemotherapy Combination in Advanced NSCLC Patients With HIV, HBV, HCV and Long Covid Syndrome

Clinical trial NCT05597800 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05597800
Sponsor: Universita di Verona
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

NSCLC Stage IV HIV HBV HCV Long COVID

Start date: 2023-02-01
Primary completion: 2026-12-31
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.